The CD14+CD16+ non-classical monocytes subpopulation is reduced in peripheral blood samples of PD patients, whereas CD14+CD16- classical monocytes are enriched compared to healthy controls [25]. This evidence concerns the gene FCGR3B and Parkinson disease.